news Mavoglurant could improve eye gaze in fragile X patients 25 January 2019 | By Iqra Farooq (Drug Target Review) A first stage trial involving the experimental drug mavoglurant has shown early success in the treatment of gaze avoidance in fragile X syndrome patients...
news New biomarker panel could accelerate autism diagnoses 17 September 2018 | By Drug Target Review Researchers have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD)...